角质形成细胞IL-33自分泌环路参与银屑病进展
该研究探讨IL-33在银屑病中的作用。研究发现角质形成细胞是皮肤中表达IL-33及其受体ST2的主要细胞,银屑病炎症刺激下角质形成细胞主动释放IL-33,以自分泌方式诱导银屑病相关细胞因子、趋化因子和炎症分子基因转录。角质形成细胞特异性IL-33缺失可改善咪喹莫特诱导的银屑病样皮炎,而皮内注射重组IL-33单独即可诱导银屑病样皮炎。
要点
- 角质形成细胞是皮肤IL-33及其受体ST2的主要表达细胞
- IL-33通过自分泌环路促进角质形成细胞产生银屑病相关炎症分子
- 角质形成细胞IL-33缺失减轻咪喹莫特诱导的银屑病样皮炎
核心结论
- 角质形成细胞中IL-33的自分泌环路促进银屑病皮肤炎症进展,IL-33是银屑病的潜在治疗靶点。
研究设计与样本
- 基础研究,涉及银屑病炎症刺激下角质形成细胞IL-33释放及自分泌作用、角质形成细胞特异性IL-33缺失对咪喹莫特诱导银屑病样皮炎的影响、皮内注射重组IL-33诱导银屑病样皮炎。
主要发现
- 角质形成细胞是皮肤中表达IL-33及其受体ST2的主要细胞。
- 银屑病炎症刺激下角质形成细胞主动释放IL-33,并以自分泌方式诱导银屑病相关细胞因子、趋化因子和炎症分子基因转录。
- 角质形成细胞特异性IL-33缺失改善咪喹莫特诱导的银屑病样皮炎。
- 皮内注射重组IL-33单独即可诱导银屑病样皮炎。
- 重组IL-33刺激下角质形成细胞中富集于IL-17、TNF和趋化因子信号通路的基因转录上调。
临床怎么用
- IL-33及其自分泌环路可作为银屑病潜在治疗靶点进行进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IL-33 is constitutively expressed in the skin. Psoriasis is a common skin inflammatory disease. The roles of IL-33 in psoriasis have not been well-elucidated. We identified that keratinocytes (KCs) are the predominant cells expressing IL-33 and its receptor, suppression of tumorigenicity 2, in the skin. KCs actively released IL-33 on psoriasis inflammatory stimuli and induced psoriasis-related cytokine, chemokine, and inflammatory molecules genes transcription in KCs in an autocrine manner. IL-33‒specific deficiency in KCs ameliorated imiquimod-induced psoriatic dermatitis. In addition, intradermal injection of recombinant IL-33 alone induced psoriasis-like dermatitis, which is attributed to the transcriptional upregulation of genes enriched in IL-17, TNF, and chemokine signaling pathway in KCs on recombinant IL-33 stimulation. Our data demonstrate that the autocrine circuit of IL-33 in KCs promotes the progression of psoriatic skin inflammation, and IL-33 is a potential therapeutic target for psoriasis.
引用
- Zeng F, Chen H, Chen L, et al. An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis. J Invest Dermatol. 2020. PMID: 32853659. doi:10.1016/j.jid.2020.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。